中概股ETF正在承壓
從2020年美國開始實施管制市場的一系列措施後,關聯中概股的ETF開始走弱,其直接原因是市場開始產生了擔憂情緒,唯恐美國出臺的管制政策將會對在美上市的中國企業產生退市的威脅。
美國證監會SEC在上週四首先直接點名了五家在美上市的中資企業,並以他們涉嫌違反外國公司問責法的理由納入臨時被識別名單。這五家分別再鼎醫藥(ZLAB.US)、百濟神州 (BGNE.US) 和和黃醫藥(ADR.US),以及半導體清潔公司 ACM Research (ACMR.US) 和百勝中國,百勝中國(YUMC.US)是肯德基、必勝客和其他快餐連鎖店的美國控股公司的子公司。此法案要求全部在美上市的外國公司必須按照美國PCAOB的會計準則進行審覈,違反此法案的公司將會面臨被退市的懲罰,這也讓那些持有美國存託憑證(ADR)的中國企業成爲首當其衝的目標。
目前看來這些中國企業都可能受到此法的打壓,因爲美國的外國公司問責法和中國涉及國家安全的審計準則相互有衝突。如這種差異持續得不到改善,未來幾年每家持有ADR的在美上市的中國企業都將面臨被退市的風險。如果此風險真的發生,全球投資者將只剩下香港市場可以投資這些類型的股票。
外國公司問責法案的出臺直接負面影響了跟蹤中概股的iShares MSCI China ETF (MCHI.US). 據3月14日數據,該ETF大跌7.19%,報45.57美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.